Aeterna Zentaris Inc. (TSX: AEZS) (NASDAQ: AEZS) Starts Presentation at NobleCon16
Aeterna Zentaris (NASDAQ: AEZS) (TSX: AEZS) is a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is the licensor and party to a license and assignment agreement with Novo Nordisk A/S to carry out joint development, manufacturing, registration, regulatory, and supply chain for the commercialization of Macrilen™ (macimorelin), for use in the diagnosis of patients with adult growth hormone deficiency in the United States and Canada. The clinical development of Macrilen(TM) for pediatric use is ongoing. Aeterna Zentaris is actively pursuing business development opportunities for Macrilen(TM) in the rest of the world and…







